Stocks
Aquestive Therapeutics, Inc.AQST
NASDAQHealthcareBiotechnology$4.13
Price as of · delayed, not real-time
A specialty pharmaceutical company focused on developing and commercializing proprietary oral film products for the treatment of central nervous system conditions. Its lead product, Libervant, is a diazepam buccal film for seizure clusters, and it also has a pipeline of film-based candidates. Investors track AQST for its commercial execution and regulatory milestones in the epilepsy space.
52W Range: $2.93-$7.18
Congressional Interest in Aquestive Therapeutics, Inc. (AQST)
No congressional trades have been disclosed for Aquestive Therapeutics, Inc. (AQST) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading AQST?
No congressional trades found for this stock.